Health News
Finding the Path of No Return for Kids with Cancer
The cure rate for one type of blood cancer that affects children - acute lymphoblastic leukemia (ALL) – is now about 80 percent. For the remaining 20 percent of kids who develop the disease, the outlook can be dire.
New Rx for Advanced Multiple Myeloma
Multiple myeloma is a blood cancer that affects nearly 22,000 Americans every year. It develops in mostly older people when plasma cells in the bone marrow grow out of control.
Serious Blood Clots a Concern for AB Blood Type
Recent research points to AB blood type as an important risk factor for developing serious blood clots. Do you know what your blood type is?
Paradigm Shift - Healthy vs. Cancerous Cells
If you focus on maintaining a healthy lifestyle, you’re less likely to get sick. That’s simple logic. Researchers now think this approach might be an effective way to treat cancer.
Take Care After Brain Bleed
Living through a brain bleed may provide a second chance to quit smoking. Kicking the habit and taking care of blood pressure and cholesterol can help keep these patients alive.
A Combination Leukemia Can’t Take
Many patients with chronic lymphocytic leukemia do pretty well with standard treatment. The disease retreats and stays in remission. However, some patients aren’t so fortunate. A new combination may be just what these patients need.
Children With Leukemia Have New Rx
Acute lymphoblastic leukemia (ALL) is the most common blood cancer found in children. It’s diagnosed in nearly 3,000 children in the United States every year and can progress quickly if left untreated. These kids now have a new treatment option.
FDA Approves Gleevec for Children With Acute Lymphoblastic Leukemia
The US Food and Drug Administration today approved a new use of Gleevec ( imatinib ) to treat children newly diagnosed with Philadelphia chromosome positive ( Ph +) acute lymphoblastic leukemia (ALL).
FDA Approves Exjade for Genetic Blood Disorder
The US Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
Cancer Trends Nobody’s Talking About
The cancer statistical bibles have been released this year. The American Cancer Society focused on the outstanding news – that cancer deaths declined 20 percent between 1991 and 2009. What wasn’t mentioned is the rising number of different types of cancers and increasing numbers of deaths estimated for this year – 2013.